New drug combo tested for Tough-to-Treat head and neck cancer
NCT ID NCT05057247
Summary
This study tested a combination of two drugs, duvelisib and docetaxel, for people with advanced head and neck cancer that had returned or spread after their first treatment stopped working. The goal was to see if this new combination could help control the cancer. About 26 people participated to measure how well the treatment worked and its side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.